FIELD: medicine; pharmaceuticals.
SUBSTANCE: there are provided: the combination of therapeutically effective amounts of the pharmaceutically acceptable zinc compound, ascorbic acid or the pharmaceutically acceptable salt and succinic acid thereof or the pharmaceutically acceptable salt thereof for enhancing the efficacy of the antibacterial drug for local application of chlorhexidine, the pharmaceutical composition of the above composition for local application with the antibacterial, anti-inflammatory and immunomodulatory effect, the combined pharmaceutical preparation for local application of the same purpose and composition, the method of prevention and treatment of acute and chronic infections of the oral cavity and throat with the use of the mentioned composition or preparation.
EFFECT: inclusion of the combination of the compound of zinc, ascorbic acid and succinic acid into the pharmaceutical composition increased the efficacy of chlorhexidine and, as a result, allowed to use these antibacterial agents at substantially lower concentrations as part of the pharmaceutical composition (in the preparation) or to use the pharmaceutical preparation in reduced doses.
11 cl, 7 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION POSSESSING ANTIBACTERIAL, ANTI-INFLAMMATORY AND IMMUNOMODULATORY ACTION, AND APPLICATION THEREOF | 2009 |
|
RU2590980C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES | 2018 |
|
RU2749902C2 |
DENTAL GEL WITH A PHYTOPELOID COMPOSITION | 2019 |
|
RU2699560C1 |
INHALATION PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF BACTERIAL INFECTIOUS DISEASES | 2022 |
|
RU2777197C1 |
DENTAL GEL | 2020 |
|
RU2749713C1 |
DENTAL GEL WITH ANTIBACTERIAL EFFECT | 2023 |
|
RU2817976C1 |
CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
AGENT FOR APPLYING ORAL AND NASAL CAVITIES AND METHOD FOR ITS USE AS PART OF COMPLEX THERAPY OF INFECTIOUS AND INFLAMMATORY DISEASES OF NASAL AND ORAL CAVITIES | 2021 |
|
RU2762506C1 |
COMBINED SOFT DOSAGE FORM FOR LOCAL TREATMENT OF PERIODONTICS | 2012 |
|
RU2508101C1 |
VETERINARY HYGIENIC EYE LOTION | 2022 |
|
RU2785343C1 |
Authors
Dates
2018-04-18—Published
2016-03-30—Filed